This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B
This 2023 Recommendation Statement from the US Preventive Services Task Force recommends that clinicians prescribe preexposure prophylaxis using effective antir
This 2022 Recommendation Statement from the US Preventive Services Task Force recommends against the use of combined estrogen and progestin for the primary prev